Mark Massaro

Mark Massaro Analyst Performance

Managing Director, Senior Equity Research Analyst at BTIG Research

Mark Massaro is a stock analyst at BTIG Research focused in the healthcare sector, covering 36 publicly traded companies. Over the past year, Mark Massaro has issued 94 stock ratings, including buy, hold, and sell recommendations. While full access to Mark Massaro's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mark Massaro's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
316 Last 12 Years
Buy Recommendations
89.35% 277 Buy Ratings
Companies Covered
36 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.3%1 ratings
Buy89.0%276 ratings
Hold8.7%27 ratings
Sell1.9%6 ratings

Out of 310 total stock ratings issued by Mark Massaro at BTIG Research, the majority (89.0%) have been Buy recommendations, followed by 8.7% Hold, 1.9% Sell, and 0.3% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
77.8% of companies on NASDAQ
28 companies
NYSE
13.9% of companies on NYSE
5 companies
OTCMKTS
8.3% of companies on OTCMKTS
3 companies

Mark Massaro, an analyst at BTIG Research, currently covers 36 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
35 companies
97.2%
Miscellaneous
1 company
2.8%

Mark Massaro of BTIG Research specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
HEALTHCARE PROVIDERS & SERVICES
9 companies
25.0%
LIFE SCIENCES TOOLS & SERVICES
8 companies
22.2%
HEALTHCARE EQUIPMENT & SUPPLIES
8 companies
22.2%
BIOTECHNOLOGY
5 companies
13.9%
HEALTHCARE TECHNOLOGY
2 companies
5.6%
Miscellaneous
1 company
2.8%
PHARMACEUTICALS
1 company
2.8%
ANALYTICAL INSTRUMENTS
1 company
2.8%
DIAGNOSTIC SUBSTANCES
1 company
2.8%

About Mark Massaro

Mark Massaro is a Managing Director and BTIG Life Science and Diagnostic Tools Analyst. Prior to BTIG, he served as the Chief Financial Officer at ArcherDX, Inc., an oncology diagnostics and pharmaceutical services company, which was acquired by Invitae Corporation. Previously, Mr. Massaro was a Managing Director and Senior Equity Research Analyst within Diagnostics and Life Science Tools at Canaccord Genuity, where he spent more than eight years focused on high-growth, precision medicine and next-generation sequencing companies, as well as molecular and point-of-care diagnostics, reference labs and animal health. He was named a “Rising Star” in Institutional Investor’s All America Survey for life science and diagnostics tools in October 2016. Earlier in his career, Mr. Massaro was an Associate Equity Analyst within Healthcare Services at Avondale Partners and held corporate finance and financial reporting roles at Dell EMC and Fidelity Investments. He earned an MBA from Babson College and a BA in economics and Spanish from the University of Massachusetts – Amherst.
Follow on LinkedIn

Mark Massaro's Ratings History at BTIG Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
11/12/2026Reiterated Rating$0.42Buy
Freenome stock logo
FRNM
Freenome
11/11/2026Reiterated Rating$11.29Buy
Exagen Inc. stock logo
XGN
Exagen
11/11/2026Reiterated Rating$5.26$9.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
11/10/2026Reiterated Rating$65.72$85.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
11/9/2026Boost Price Target$34.38$52.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
11/5/2026Reiterated Rating$113.89$130.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
11/5/2026Reiterated Rating$33.22$38.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
11/3/2026Boost Price Target$78.48$100.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
10/30/2026Dropped Coverage$79.67$160.00Buy
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10/30/2026Dropped Coverage$551.21Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
10/29/2026Reiterated Rating$17.99$28.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
10/27/2026Boost Price Target$32.46$38.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
10/27/2026Boost Price Target$69.10$81.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
10/27/2026Boost Price Target$173.25$210.00Buy
Natera, Inc. stock logo
NTRA
Natera
10/27/2026Boost Price Target$404.90$430.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/26/2026Reiterated Rating$67.61$80.00Buy
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
10/23/2026Reiterated Rating$0.33Buy
MDxHealth SA stock logo
MDXH
MDxHealth
10/19/2026Downgrade$0.21Neutral
Personalis, Inc. stock logo
PSNL
Personalis
10/6/2026Downgrade$16.40Neutral
CareDx, Inc. stock logo
CDNA
CareDx
9/24/2026Boost Price Target$54.31$74.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
9/22/2026Boost Price Target$27.86$34.00Buy
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
9/4/2026Reiterated Rating$6.93$5.00Sell
Guardant Health, Inc. stock logo
GH
Guardant Health
9/2/2026Reiterated Rating$164.41$195.00Buy
MDxHealth SA stock logo
MDXH
MDxHealth
8/21/2026Lower Price Target$0.72$2.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
8/20/2026Boost Price Target$61.25$80.00Buy
Freenome stock logo
FRNM
Freenome
8/17/2026Initiated Coverage$11.56$17.00Buy
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
8/17/2026Reiterated Rating$0.97$2.50Buy
Freenome stock logo
FRNM
Freenome
8/17/2026Initiated Coverage$13.00$17.00Buy
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
8/11/2026Upgrade$6.72$8.00Buy
Natera, Inc. stock logo
NTRA
Natera
8/7/2026Boost Price Target$265.38$320.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
8/6/2026Boost Price Target$20.00$33.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
8/6/2026Lower Price Target$149.97$130.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
8/6/2026Boost Price Target$45.50$60.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
8/5/2026Boost Price Target$6.84$9.00Buy
Exagen Inc. stock logo
XGN
Exagen
8/5/2026Boost Price Target$6.45$9.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
8/4/2026Reiterated Rating$67.86$90.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
8/3/2026Boost Price Target$28.00$44.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
8/3/2026Lower Price Target$46.74$70.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
7/31/2026Boost Price Target$152.35$195.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
7/30/2026Boost Price Target$22.56$25.00Buy
Worse than socialism (Ad)

Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel

Watch Porter Stansberry's full investment broadcast now
Personalis, Inc. stock logo
PSNL
Personalis
7/20/2026Boost Price Target$13.68$16.25Buy
CareDx, Inc. stock logo
CDNA
CareDx
7/16/2026Boost Price Target$37.31$45.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
7/2/2026Reiterated Rating$18.75$32.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
7/1/2026Boost Price Target$165.84$190.00Buy
Natera, Inc. stock logo
NTRA
Natera
6/24/2026Set Price Target$260.53$275.00Buy
Natera, Inc. stock logo
NTRA
Natera
6/23/2026Boost Price Target$235.22$270.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
6/17/2026Reiterated Rating$16.79$22.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
6/15/2026Reiterated Rating$4.88$8.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
6/1/2026Reiterated Rating$50.47$80.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/27/2026Set Price Target$125.59$160.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/26/2026Boost Price Target$118.95$155.00Buy
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
5/15/2026Reiterated Rating$1.02$2.50Buy
MDxHealth SA stock logo
MDXH
MDxHealth
5/14/2026Lower Price Target$1.95$4.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
5/13/2026Lower Price Target$18.63$40.00Buy
Exagen Inc. stock logo
XGN
Exagen
5/12/2026Lower Price Target$3.98$8.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
5/11/2026Lower Price Target$5.98$11.00Buy
Natera, Inc. stock logo
NTRA
Natera
5/11/2026Lower Price Target$200.24$250.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
5/8/2026Lower Price Target$19.84$32.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
5/8/2026Lower Price Target$49.02$80.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
5/7/2026Lower Price Target$81.40$130.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
5/6/2026Reiterated Rating$13.78$22.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
5/6/2026Reiterated Rating$5.07$8.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
5/5/2026Lower Price Target$67.93$90.00Buy
Cerus Corporation stock logo
CERS
Cerus
5/1/2026Upgrade$2.03$4.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
4/29/2026Boost Price Target$21.91$28.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4/15/2026Boost Price Target$4.96$8.00Buy
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3/30/2026Reiterated Rating$1.12$2.50Buy
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
3/24/2026Dropped Coverage$104.91Neutral
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
3/12/2026Lower Price Target$6.84$5.00Sell
Exagen Inc. stock logo
XGN
Exagen
3/10/2026Lower Price Target$3.33$9.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
3/5/2026Lower Price Target$80.83$140.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
3/3/2026Reiterated Rating$4.04$7.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
2/27/2026Lower Price Target$19.24$38.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
2/26/2026Reiterated Rating$129.15$160.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
2/25/2026Boost Price Target$18.46$26.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
2/25/2026Lower Price Target$57.95$90.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2/24/2026Lower Price Target$87.08$170.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$106.38$145.00Buy
Exagen Inc. stock logo
XGN
Exagen
2/17/2026Lower Price Target$3.28$10.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
2/11/2026Boost Price Target$8.90$13.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
2/6/2026Boost Price Target$16.47$22.00Buy
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2/3/2026Lower Price Target$639.60$800.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
1/9/2026Reiterated Rating$8.38$12.00Buy
MDxHealth SA stock logo
MDXH
MDxHealth
12/23/2025Reiterated Rating$3.40$7.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
12/12/2025Boost Price Target$101.38$140.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
12/12/2025Boost Price Target$155.37$200.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
12/12/2025Boost Price Target$37.97$50.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/10/2025Reiterated Rating$109.53$160.00Buy
Natera, Inc. stock logo
NTRA
Natera
12/5/2025Boost Price Target$244.55$260.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
12/3/2025Reiterated Rating$124.44$160.00Buy
What the hell is going on? (Ad)

Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel

Watch Porter Stansberry's full broadcast on the coming dollar reset now
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/1/2025Initiated Coverage$130.18$160.00Buy
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/1/2025Initiated Coverage$113.04$160.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
11/25/2025Boost Price Target$76.06$105.00Buy
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/20/2025Downgrade$100.99Neutral
MDxHealth SA stock logo
MDXH
MDxHealth
11/13/2025Boost Price Target$4.12$7.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
11/12/2025Lower Price Target$120.09$160.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
11/11/2025Boost Price Target$8.63$12.00Buy
Exagen Inc. stock logo
XGN
Exagen
11/10/2025Boost Price Target$9.56$15.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
11/10/2025Boost Price Target$4.37$7.00Buy
Natera, Inc. stock logo
NTRA
Natera
11/7/2025Boost Price Target$198.48$230.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
11/6/2025Boost Price Target$15.56$21.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
11/6/2025Boost Price Target$16.53$25.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
11/5/2025Reiterated Rating$84.49$96.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
11/4/2025Boost Price Target$31.63$38.00Buy
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11/4/2025Boost Price Target$722.94$830.00Buy
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/4/2025Boost Price Target$66.98$85.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
10/30/2025Boost Price Target$72.27$100.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/29/2025Boost Price Target$137.47$165.00Buy
Natera, Inc. stock logo
NTRA
Natera
10/23/2025Boost Price Target$192.51$210.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/22/2025Boost Price Target$89.10$96.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
10/22/2025Boost Price Target$9.57$11.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/22/2025Boost Price Target$121.77$140.00Buy
Exagen Inc. stock logo
XGN
Exagen
10/22/2025Boost Price Target$11.69$13.00Buy
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
10/22/2025Boost Price Target$63.41$75.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
10/22/2025Boost Price Target$17.35$19.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Set Price Target$61.04$80.00
CareDx, Inc. stock logo
CDNA
CareDx
9/23/2025Reiterated Rating$14.99$22.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/22/2025Reiterated Rating$59.15$70.00Buy
CareDx, Inc. stock logo
CDNA
CareDx
9/12/2025Reiterated Rating$13.53$22.00Buy
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
9/5/2025Boost Price Target$1.38$2.50Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/4/2025Boost Price Target$59.08$70.00Buy
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
8/25/2025Boost Price Target$12.51$9.00Sell
Tempus AI, Inc. stock logo
TEM
Tempus AI
8/20/2025Boost Price Target$73.08$85.00Buy
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
8/12/2025Lower Price Target$41.52$60.00Buy
MaxCyte, Inc. stock logo
MXCT
MaxCyte
8/11/2025Reiterated Rating$1.38Neutral
Tempus AI, Inc. stock logo
TEM
Tempus AI
8/8/2025Initiated Coverage$58.74$60.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
8/6/2025Set Price Target$4.52$6.00
Tempus AI, Inc. stock logo
TEM
Tempus AI
4/21/2025Initiated Coverage$40.42$60.00Buy
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3/12/2025Set Price Target$3.47$6.00Buy
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
12/11/2024Upgrade$1.35Strong-Buy